Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension

被引：20
|
作者：
Anthi, Anastasia [1 ,2 ]
Tsangaris, Iraklis [1 ,2 ]
Hamodraka, Eftichia S. [3 ]
Lekakis, John [2 ,3 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Crit Care 2, Attikon Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Pulm Hypertens Clin, Attikon Gen Hosp, GR-11527 Athens, Greece
[3] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Gen Hosp, GR-11527 Athens, Greece
来源：
BLOOD | 2012年 / 120卷 / 07期
关键词：
SICKLE-CELL-DISEASE; SILDENAFIL;
D O I：
10.1182/blood-2012-04-422568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1531 / 1532
页数：4
相关论文
共 50 条
  • [31] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects
    Sitbon, O.
    Beghetti, M.
    Petit, J.
    Iserin, L.
    Humbert, M.
    Gressin, V.
    Simonneau, G.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 25 - 31
  • [32] Bosentan in pulmonary arterial hypertension secondary to scleroderma
    Joglekar, A
    Tsai, FS
    McCloskey, DA
    Wilson, JE
    Seibold, JR
    Riley, DJ
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 61 - 68
  • [33] Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension
    Strange, Geoff
    Keogh, Anne
    Dalton, Brad
    Gabbay, Eli
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (03) : 253 - 263
  • [34] Bosentan combined with sildenafil in the treatment of COPD patients with pulmonary arterial hypertension
    Li, Ying
    Wang, Yao
    Liu, Shaohua
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 11522 - 11530
  • [35] ADVERSE EFFECTS OF BOSENTAN IN PATIENT WITH SSc-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Egashira, S.
    Makino, T.
    Jinnin, M.
    Ihn, H.
    RHEUMATOLOGY, 2012, 51 : 99 - 100
  • [36] The bosentan patient registry: long-term survival in pulmonary arterial hypertension
    Keogh, A.
    Strange, G.
    McNeil, K.
    Williams, T. J.
    Gabbay, E.
    Proudman, S.
    Weintraub, R. G.
    Wlodarczyk, J.
    Dalton, B.
    INTERNAL MEDICINE JOURNAL, 2011, 41 (03) : 227 - 234
  • [37] Edema in Patient Switched to Macitentan from Bosentan and Ambrisentan in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Thakur, Aishwarya
    Frost, Adaani
    CHEST, 2015, 148 (04)
  • [38] Bosentan in Pediatric Patients with Pulmonary Arterial Hypertension
    Beghetti, Maurice
    CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (02) : 225 - 233
  • [39] Review of bosentan in the management of pulmonary arterial hypertension
    Gabbay, Eli
    Fraser, John
    McNeil, Keith
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (06) : 887 - 900
  • [40] Bosentan: In pediatric patients with pulmonary arterial hypertension
    Carter N.J.
    Keating G.M.
    Pediatric Drugs, 2010, 12 (1) : 63 - 73
12345